The immune escape function of IDO1 in cancer was first reported in 2002 by Friberg et al.19Currently, more and more studies have demonstrated that IDO1 is associated with immune escape by suppressing T cell activity and enhancing Treg in different tumour types. Here, IDO1 is linked to neoplasm.